Long-term outcomes of vindesine or vincristine substitutions for vinblastine in classical Hodgkin lymphoma
Year: 2026
Type: article
Source: Chinese Medical Journal
Authors: Yu Fang, Min Bai, Yao Liu, Jianhong Wang, Hui Geng, Liyun He, Xiaoxi Zhou, Fang Zhu, Weicheng Zheng, Mingyi Di, Kai Hu, Huimin Liu, Fuling Zhou, Huiqiang Huang, Yi Xia, Rui Cao, Yafen Xiong, Weiying Gu, Yu Xie, Xiongpeng Zhu, Shaoxiong Wang, Jing Yang, Jingwei Yu, Chenchen Wang, Rong Liang, Liping Su, Qingqing Cai
Institutions: Sun Yat-sen University, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Shanxi Provincial Cancer Hospital, Chongqing University, Chongqing Cancer Hospital, Air Force Medical University, Qinghai University Affiliated Hospital, Tongji Hospital, Huazhong University of Science and Technology, Second Affiliated Hospital of Soochow University, Peking University First Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Institute of Hematology & Blood Diseases Hospital, State Key Laboratory of Experimental Hematology, Zhongnan Hospital of Wuhan University, Soochow University, The First People's Hospital of Changzhou, First Affiliated Hospital of Kunming Medical University, Fujian Medical University, Beijing Tongren Hospital, Capital Medical University, Tianjin Medical University Cancer Institute and Hospital, Jilin University
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,000
OpenAlex ID: W7204070547